These results suggest that the low ROS level generated by baicalin in tumor cells, resulted in the upregulation of DEPP and the activation of Ras/Raf/MEK/ERK and p16INK4A/Rb pathways. The gene discussed is CDKN2A; the disease is neoplasm.